FDA establishment 3010453141, Pithampur, District Dhar, India. Part of Mylan Laboratories's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations, and the shipments FDA refused at the border.
FY2018 to FY2027 to date; 0 classified OAI
A hatched bar is a year that is not over, so its count covers only part of the year.
| May 24, 2019 | Drugs · Drug Quality Assurance | None posted | No Action Indicated (NAI) |
| Feb 5, 2016 | Drugs · Drug Quality Assurance | None posted | Voluntary Action Indicated (VAI) |
| Mar 14, 2014 | Drugs · Drug Quality Assurance | None posted | Voluntary Action Indicated (VAI) |
| ABACAVIR SULFATE; LAMIVUDINE (ANTI-VIRAL)Drugs · 62VDA67 | Jul 20, 2026 | |
| TENOFOVIR DISOPROXIL FUMERATEDrugs · 62VDA15 | Jan 30, 2026 | |
| LEVOTHYROXINE SODIUM (THYROID HORMONE)Drugs · 66JCA01 | Apr 8, 20252 lines | |
| TENOFOVIR DISOPROXIL FUMERATEDrugs · 62VCY15 | Jan 21, 2025 | |
| ANTI-VIRAL N.E.C.Drugs · 62VDA99 | Oct 16, 2024 | |
| DOLUTEGRAVIR SODIUM (ANTI-VIRAL)Drugs · 62VDA73 | Apr 29, 2024 |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. FDA Data Dashboard, warning letters and enforcement reports